跳至主要内容
临床试验/NL-OMON24455
NL-OMON24455招募中不适用

Endoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett’s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.

Academic Medical Center, Amsterdam0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
84

研究概览

简要总结

Curvers WL, Wong Kee Song LM, Wang K, Gostout CJ, Wallace MB, Wolfsen HC, Ragunath R, Fockens P, Bergman JJ. Endoscopic Tri-Modal Imaging (ETMI) for the Detection of Dysplastic Lesions in Barrett's Esophagus; a multi-centre feasibility study. Endosc 2006; 38 (suppl II) A34.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age > 18 years;
  • 2. Prior diagnosis of BE defined as the presence of columnar lined epithelium in the tubular esophagus with specialised intestinal metaplasia on histological investigation;
  • 3. Prior diagnosis of high-grade dysplasia or early cancer that was endoscopically inconspicuous according to the referring physician. Review of the pathology slides is not required for inclusion;
  • 4. A minimum Barrett’s length of C>2M>2 or C<2M>4 according to the Prague C&M classification of the endoscopic appearance of BE;
  • 4. Written informed consent.

排除标准

  • 1. Presence of active erosive esophagitis > grade A according to the Los Angles classification of erosive esophagitis;
  • 2. Description of an endoscopically visible suspicious lesion in the Barrett’s segment in the referring center;
  • 3. Presence of conditions precluding histological sampling of the esophagus (e.g. esophageal varices, coagulation disorders, anticoagulant therapy);
  • 4. At the first endoscopy: the presence of a type 0-I or type 0-III lesion or a lesion that, according to the discretion of the endoscopist, does not allow a delay in intervention for a period of 6 weeks (interval between the two cross-over endoscopies).

研究者

发起方
Academic Medical Center, Amsterdam

相似试验